Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) has earned an average rating of “Hold” from the twenty-one analysts that are currently covering the company, Marketbeat.com reports. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $12.24.
A number of brokerages have issued reports on TDOC. TD Cowen reduced their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Jefferies Financial Group lifted their target price on Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a report on Tuesday, September 17th. Evercore ISI increased their price target on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Royal Bank of Canada lifted their price objective on Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Finally, The Goldman Sachs Group initiated coverage on Teladoc Health in a research report on Friday, November 15th. They set a “buy” rating and a $14.00 target price for the company.
Get Our Latest Analysis on TDOC
Insider Transactions at Teladoc Health
Hedge Funds Weigh In On Teladoc Health
A number of institutional investors have recently modified their holdings of TDOC. Signaturefd LLC grew its stake in Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,715 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Teladoc Health in the 2nd quarter worth $29,000. Versant Capital Management Inc grew its position in shares of Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares in the last quarter. Blue Trust Inc. increased its stake in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after buying an additional 1,854 shares during the period. Finally, Doheny Asset Management CA bought a new stake in shares of Teladoc Health in the second quarter valued at about $46,000. 76.82% of the stock is owned by hedge funds and other institutional investors.
Teladoc Health Price Performance
Shares of Teladoc Health stock opened at $9.79 on Thursday. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of -1.70 and a beta of 1.01. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock’s 50-day simple moving average is $9.94 and its 200-day simple moving average is $9.04. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.16.
Teladoc Health (NYSE:TDOC – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. As a group, analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
- Five stocks we like better than Teladoc Health
- How to Effectively Use the MarketBeat Ratings Screener
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What is a Dividend King?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.